This report is an extensive analysis of current and potential trends in the Anxiety Disorders market. The report provides an in-depth quantitative analysis of the current and future market estimations which helps to recognize the prevailing market opportunities. Key market players within the market are profiled in this report and their strategies are analysed completely which help to understand the competitive outlook 2020-2024.
Global Anxiety Disorders Market Overview:
The report provides actionable insights to improve source-to-contract cycle performance in the Global Anxiety Disorders Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
Anxiety Disorders are the most common psychiatric disorders affecting a huge population across the globe. Anxiety Disorders is related to a state of emotion that further affects actions, thoughts and sometimes the sleeping pattern of the concerned person. Anxiety Disorders is a reaction to stress. Extreme level of anxiety result in anxiety disorders which include phobias, obsessive-compulsive disorder, panic disorder, post-traumatic based stress disorder.
The growing aged populace, reduced side effects and more efficiency of innovative drugs along with the hastening occurrence of anxiety disorders are subsidizing towards the increase of this market. Though, mounting numbers of different aged drugs are analysed to obstruct the anxiety disorders and depression treatment market growth. The prospect of innovations and expansions in herbal remedies with an enhanced distribution system is offers probable opportunities for the key participants.
The global anxiety disorders market is estimated to see a minor collapse in upcoming years. The growing number of patent expiry is one of the key factors that are predictable to hinder the rise of the global on the next few years. However, with the growing responsiveness among consumers and the fast expansion of the healthcare segment, specifically in the evolving economies are predicted to enhance the growth of the overall market in the next few years. In addition to this, the advent of new technologies and treatments is foreseen to offer possible growth chances for the market players, which is predictable to backing the rise of the global anxiety disorders market in the forecasts year.
The global Anxiety Disorders market is marked by some strong competition from the major players operating in this industry. Many merger and acquisition, joint venture and partnership agreement, product innovation, research and development and geographical extension are some of the key strategies adopted by this player to ensure long term sustenance in these market key participants in the global Anxiety Disorders industry include
Express Scripts… more
The Anxiety Disorders market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
Product Type Segmentation
Major Depressive Disorder (MDD)
Obsessive-Compulsive Disorder (OCD)
The key regional segments, North America is predictable to account for a big share of the global market in the upcoming year. The robust progress of this region can be recognized to the occurrence of a huge number of patients who are suffering from different types of anxiety disorders. In addition to this, the rising awareness among patients regarding the availability of boosted drugs and treatments is projected to augment the rise of the North America market in the forecasts period. On the other side, Asia Pacific is expected to witness a healthy growth in the upcoming years, the growing occurrence of psychiatric disorders. Furthermore, the rapid progress of the economy in the nations, such as Japan, China, and Australia is estimated to improve the growth of the market in the forecasts period.
Global Industry News:
Iora Health : Feb 10, 2020
Iora Health Raises $126M to Grow its Primary Care Network, Refine Care Model
Boston-based Iora Health, a company that aims to reinvent primary care through its own primary care practices, raised $126 million in a Series F funding round.
The investment was led by India-based Premji Invest, the investment group of Wipro Ltd chairman Azim Premji, and existing investors Cox Enterprises, Temasek Holdings, F-Prime Capital, Devonshire Investors, .406 Ventures, Flare Capital Partners, Polaris Partners, and Khosla Ventures participated.
The ten-year-old company’s previous backers include GE Ventures and Rice Management Company. It has raised a total of $381.5 million in venture funding to date.
Iora Health’s model is to open up primary care centers for the Medicare population. Typically, these centers are based in a retail environment, often next to a drug store or supermarket. The company establishes care teams consisting of up to three primary care physicians, nurse practitioners, health and behavioral coaches.
Iora Health claims its patients averaged over four visits in 2019 across its 48 practices with twice as many electronic interactions with their care teams.
According to Kathleen Haley, vice president of marketing and communications, capital infusion from this round will be directed towards three main focus areas: directed towards three main focus areas: To bolster its proprietary care platform, Chirp, to be certified as a Medicare Certified Electronic Health Records system (this will make the platform capable of generating standardized patient information to be shared with specialists outside of the company’s network through an encrypted messaging protocol), to “optimize and refine its care model,” by serving more patients in its network, and to expand its network by adding more practices in its current markets. The company opened practices in Texas, North Carolina and Georgia last year.
Major Points Covered
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
Major Points in Table of Contents:
Global Anxiety Disorders Market Report 2020
1 Anxiety Disorders Product Definition
2 Global Anxiety Disorders Market Manufacturer Share and Market Overview
3 Manufacturer Anxiety Disorders Business Introduction
4 Global Anxiety Disorders Market Segmentation (Region Level)
5 Global Anxiety Disorders Market Segmentation (Product Type Level)
6 Global Anxiety Disorders Market Segmentation (Industry Level)
7 Global Anxiety Disorders Market Segmentation (Channel Level)
8 Anxiety Disorders Market Forecast 2020-2025
9 Anxiety Disorders Segmentation Product Type
10 Anxiety Disorders Segmentation Industry